Skip to main content
Drug Development
Our Pipeline
Therapeutic areas
Partnering
News
Investors
Regulatory News
AIM Rule 26
Annual and Half Yearly Reports
Admission Document & Articles
Shareholder communications
Investments Calculator
Share Alerts
Share Series
Share price look-up
About us
Board of Directors and Management Team
Strategy and Vision
How we work
Working with us
Our subsidiaries
Contact us
Search
Our CEO discusses the VAL201 Clinical Trial results with BRR Media
30 Nov 2020
Videos and audiocasts
Breadcrumb
Home
News
